-
-
-
-
-
-
-
Indaptus Therapeutics (INDP) Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
-
-
-
-
-
-
-
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

